BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29120638)

  • 1. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).
    Rai G; Brimacombe KR; Mott BT; Urban DJ; Hu X; Yang SM; Lee TD; Cheff DM; Kouznetsova J; Benavides GA; Pohida K; Kuenstner EJ; Luci DK; Lukacs CM; Davies DR; Dranow DM; Zhu H; Sulikowski G; Moore WJ; Stott GM; Flint AJ; Hall MD; Darley-Usmar VM; Neckers LM; Dang CV; Waterson AG; Simeonov A; Jadhav A; Maloney DJ
    J Med Chem; 2017 Nov; 60(22):9184-9204. PubMed ID: 29120638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties.
    Rai G; Urban DJ; Mott BT; Hu X; Yang SM; Benavides GA; Johnson MS; Squadrito GL; Brimacombe KR; Lee TD; Cheff DM; Zhu H; Henderson MJ; Pohida K; Sulikowski GA; Dranow DM; Kabir M; Shah P; Padilha E; Tao D; Fang Y; Christov PP; Kim K; Jana S; Muttil P; Anderson T; Kunda NK; Hathaway HJ; Kusewitt DF; Oshima N; Cherukuri M; Davies DR; Norenberg JP; Sklar LA; Moore WJ; Dang CV; Stott GM; Neckers L; Flint AJ; Darley-Usmar VM; Simeonov A; Waterson AG; Jadhav A; Hall MD; Maloney DJ
    J Med Chem; 2020 Oct; 63(19):10984-11011. PubMed ID: 32902275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of ether and aniline based inhibitors of lactate dehydrogenase.
    Christov PP; Kim K; Jana S; Romaine IM; Rai G; Mott BT; Allweil AA; Lamers A; Brimacombe KR; Urban DJ; Lee TD; Hu X; Lukacs CM; Davies DR; Jadhav A; Hall MD; Green N; Moore WJ; Stott GM; Flint AJ; Maloney DJ; Sulikowski GA; Waterson AG
    Bioorg Med Chem Lett; 2021 Jun; 41():127974. PubMed ID: 33771585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and structural optimization of pyrazole derivatives as novel inhibitors of Cdc25B.
    Chen HJ; Liu Y; Wang LN; Shen Q; Li J; Nan FJ
    Bioorg Med Chem Lett; 2010 May; 20(9):2876-9. PubMed ID: 20363629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel serine palmitoyltransferase inhibitors as cancer therapeutic agents.
    Kojima T; Asano Y; Kurasawa O; Hirata Y; Iwamura N; Wong TT; Saito B; Tanaka Y; Arai R; Yonemori K; Miyamoto Y; Sagiya Y; Yaguchi M; Shibata S; Mizutani A; Sano O; Adachi R; Satomi Y; Hirayama M; Aoyama K; Hiura Y; Kiba A; Kitamura S; Imamura S
    Bioorg Med Chem; 2018 May; 26(9):2452-2465. PubMed ID: 29669694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities.
    Kim KS; Kimball SD; Misra RN; Rawlins DB; Hunt JT; Xiao HY; Lu S; Qian L; Han WC; Shan W; Mitt T; Cai ZW; Poss MA; Zhu H; Sack JS; Tokarski JS; Chang CY; Pavletich N; Kamath A; Humphreys WG; Marathe P; Bursuker I; Kellar KA; Roongta U; Batorsky R; Mulheron JG; Bol D; Fairchild CR; Lee FY; Webster KR
    J Med Chem; 2002 Aug; 45(18):3905-27. PubMed ID: 12190313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the first highly selective inhibitor of human lactate dehydrogenase B.
    Shibata S; Sogabe S; Miwa M; Fujimoto T; Takakura N; Naotsuka A; Kitamura S; Kawamoto T; Soga T
    Sci Rep; 2021 Nov; 11(1):21353. PubMed ID: 34725423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.
    Wei B; Robarge K; Labadie SS; Chen J; Corson LB; DiPasquale A; Dragovich PS; Eigenbrot C; Evangelista M; Fauber BP; Hitz A; Hong R; Lai KW; Liu W; Ma S; Malek S; O'Brien T; Pang J; Peterson D; Salphati L; Sampath D; Sideris S; Ultsch M; Xu Z; Yen I; Yu D; Yue Q; Zhou A; Purkey HE
    Bioorg Med Chem Lett; 2022 Mar; 59():128576. PubMed ID: 35065235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase.
    Fauber BP; Dragovich PS; Chen J; Corson LB; Ding CZ; Eigenbrot C; Giannetti AM; Hunsaker T; Labadie S; Liu Y; Liu Y; Malek S; Peterson D; Pitts K; Sideris S; Ultsch M; VanderPorten E; Wang J; Wei B; Yen I; Yue Q
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5533-9. PubMed ID: 24012183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design, synthesis, and biological evaluation of dihydroquinazoline-derived potent β-secretase inhibitors.
    Ghosh AK; Pandey S; Gangarajula S; Kulkarni S; Xu X; Rao KV; Huang X; Tang J
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5460-5. PubMed ID: 22863204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors.
    Kohlmann A; Zech SG; Li F; Zhou T; Squillace RM; Commodore L; Greenfield MT; Lu X; Miller DP; Huang WS; Qi J; Thomas RM; Wang Y; Zhang S; Dodd R; Liu S; Xu R; Xu Y; Miret JJ; Rivera V; Clackson T; Shakespeare WC; Zhu X; Dalgarno DC
    J Med Chem; 2013 Feb; 56(3):1023-40. PubMed ID: 23302067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma.
    Yeung C; Gibson AE; Issaq SH; Oshima N; Baumgart JT; Edessa LD; Rai G; Urban DJ; Johnson MS; Benavides GA; Squadrito GL; Yohe ME; Lei H; Eldridge S; Hamre J; Dowdy T; Ruiz-Rodado V; Lita A; Mendoza A; Shern JF; Larion M; Helman LJ; Stott GM; Krishna MC; Hall MD; Darley-Usmar V; Neckers LM; Heske CM
    Cancer Res; 2019 Oct; 79(19):5060-5073. PubMed ID: 31431459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivity-guided identification and cell signaling technology to delineate the lactate dehydrogenase A inhibition effects of Spatholobus suberectus on breast cancer.
    Wang Z; Wang D; Han S; Wang N; Mo F; Loo TY; Shen J; Huang H; Chen J
    PLoS One; 2013; 8(2):e56631. PubMed ID: 23457597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
    Calvaresi EC; Granchi C; Tuccinardi T; Di Bussolo V; Huigens RW; Lee HY; Palchaudhuri R; Macchia M; Martinelli A; Minutolo F; Hergenrother PJ
    Chembiochem; 2013 Nov; 14(17):2263-7. PubMed ID: 24174263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
    Chen CY; Feng Y; Chen JY; Deng H
    Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
    Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase.
    Dragovich PS; Fauber BP; Boggs J; Chen J; Corson LB; Ding CZ; Eigenbrot C; Ge H; Giannetti AM; Hunsaker T; Labadie S; Li C; Liu Y; Liu Y; Ma S; Malek S; Peterson D; Pitts KE; Purkey HE; Robarge K; Salphati L; Sideris S; Ultsch M; VanderPorten E; Wang J; Wei B; Xu Q; Yen I; Yue Q; Zhang H; Zhang X; Zhou A
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3764-71. PubMed ID: 25037916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
    Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; Pittalà V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
    Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B).
    Zhao B; Liang Q; Ren H; Zhang X; Wu Y; Zhang K; Ma LY; Zheng YC; Liu HM
    Eur J Med Chem; 2020 Apr; 192():112161. PubMed ID: 32155529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
    Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
    Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.